Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development of novel targeted therapies in the treatment of malignant glioma.

× No keyword cloud information.

85 in total

1. mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells.

Authors: Federico Bolognani; Anne-Isabelle Gallani; Lena Sokol; David S Baskin; Nicole Meisner-Kober
Journal: J Neurooncol Date: 2011-09-21 Impact factor: 4.130

2. Neuro-oncology in a nutshell.

Authors: Joachim M Baehring
Journal: J Neurooncol Date: 2004-10 Impact factor: 4.130

3. Cerebral radiation injury and changes in the brain tissues of rat models with glioma.

Authors: Lin Sha; Qian Cao; Li Lv; Guoguang Fan
Journal: Tumour Biol Date: 2013-11-07

Review 4. Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression.

Authors: J Carlsson; Z P Ren; K Wester; A L Sundberg; N E Heldin; G Hesselager; M Persson; L Gedda; V Tolmachev; H Lundqvist; E Blomquist; M Nistér
Journal: J Neurooncol Date: 2006-03 Impact factor: 4.130

5. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.

Authors: Peter Hau; Leoni A Kunz-Schughart; Petra Rümmele; Füsun Arslan; Anett Dörfelt; Horst Koch; Annette Lohmeier; Birgit Hirschmann; Adolf Müller; Ulrich Bogdahn; Anja-Katrin Bosserhoff
Journal: J Neurooncol Date: 2005-11-15 Impact factor: 4.130

Review 6. Chemotherapy for malignant brain tumors of childhood.

Authors: Nicholas G Gottardo; Amar Gajjar
Journal: J Child Neurol Date: 2008-10 Impact factor: 1.987

Review 7. Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies.

Authors: Nikhil G Thaker; Ian F Pollack
Journal: Expert Rev Neurother Date: 2009-12 Impact factor: 4.618

Review 8. Improving Diagnostic and Therapeutic Outcomes in Pediatric Brain Tumors.

Authors: Sydney T Grob; Jean M Mulcahy Levy
Journal: Mol Diagn Ther Date: 2018-02 Impact factor: 4.074

9. Identification of survival genes in human glioblastoma cells by small interfering RNA screening.

Authors: Nikhil G Thaker; Fang Zhang; Peter R McDonald; Tong Ying Shun; Michael D Lewen; Ian F Pollack; John S Lazo
Journal: Mol Pharmacol Date: 2009-09-25 Impact factor: 4.436

Review 10. Targeting astrocytomas and invading immune cells with cannabinoids: a promising therapeutic avenue.

Authors: Eiron Cudaback; Nephi Stella
Journal: Mol Neurobiol Date: 2007-07-03 Impact factor: 5.590